Neonatal recognition of familial dysautonomia

respiratory distress syndrome. It is unclear why SOD appeared to be effective in modifying pulmonary disease in human infants at relatively low doses, yet failed to modify sequelae in the present animal models, despite substantially higher doses of the enzyme. The lungs of both the preterm infant (